Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PENTOXIFYLLINE USP, with a corresponding US DMF Number 14987.
Remarkably, this DMF maintains an Active status since its submission on July 25, 2000, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 30, 2025, and payment made on September 25, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II